When the FDA approved an RSV vaccine for infants in July of 2023, parents and pediatricians rejoiced. But product shortages and a patchwork of insurance coverage throttled the rollout, leaving many babies still unprotected this winter. Pediatrician and Internist Dr. Wendie Grader-Beck talks with Dr. Josh Sharfstein about her frustrations around implementation, and what needs to be done before the next RSV season for this lifesaving technology to fulfill its promise.
